Abstract
Despite of the advancements in treating cancer, it is yet one of the dominant causes of death worldwide. The current therapies are either incapable against certain cancers or impeding to the patients, which diminishes their personal satisfaction. The utilization of nanoparticles in cancer treatment might possibly increment patient endurance, decrease secondary effects and diminish death rates. The fundamental constraint of current therapeutics is an absence of explicitness in conveyance as they target normal cells too. The advancement of nanoscale carriers can possibly defeat both fundamental and growth hindrances as well as give explicit, designated conveyance. This study also aims to focus on the therapeutic strategies in which different types of nanoparticles have been discussed comprehensively. Moreover, cancer nanomedicines have also been addressed in the end to highlight some more possible therapeutic measures.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
